|
|
Article: UK's NICE issues chronic hand eczema appraisal doc.
- Article from:
- Pharma Marketletter
- Article date:
- May 18, 2009
CopyrightCOPYRIGHT 2009 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The National Institute for Health and Clinical Excellence (NICE), which determines which drugs should be covered by the UK National Health Service outside Scotland, has issued its preliminary recommendation in favor of Swiss drugmaker Basilea Pharmaceutica's Toctino (alitretinoin) for patients with chronic hand eczema. The Institute proposes that the agent be used once-a day for adults with the condition who ...
Related newspaper, magazine, and journal articles:
|
|
Article: Disulfiram and low nickel diet in the management of hand ...
Indian Journal of Dermatology, Venereology and Leprology;
March 1, 2006 ;
700+ words
...Hand eczema is a common and distressing dermatological ... problem. The exact prevalence rate of hand eczema in India is not known. However, in ... in the age group of 16-19 years. Hand eczema is caused by various exogenous and endogenous ...
|
|